Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Results of a phase III trial investigating Brentuximab Vedotin combined with chemotherapy for first line treatment of Hodgkin lymphoma.